The association between antihypertensive drugs and glioma

British Journal of Cancer

Volumn 94, Issue 5, 2006, Pages 752-756

  Houben, M P W A ^a,b   Coebergh, J W W ^b,c   Herings, R M C ^d   Casparie, M K ^e   Tijssen, C C ^a   Van Duijn, C M ^b   Stricker, B H Ch ^b  

^a CPRLab   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c The Netherlands   (Netherlands)

^d PHARMO INSTITUTE FOR DRUG OUTCOMES RESEARCH   (Netherlands)

^e Foundation PALGA   (Netherlands)

Author keywords

Antihypertensive drugs; Case control study; Glioma; Pharmaco epidemiology; Risk

Indexed keywords

ANGIOTENSIN ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; AGED; ARTICLE; BRAIN TUMOR; CANCER INCIDENCE; CANCER PATIENT; CANCER RISK; CONTROLLED STUDY; CYTOPATHOLOGY; DISEASE ASSOCIATION; ENVIRONMENTAL FACTOR; FEMALE; FOLLOW UP; GLIOMA; HISTOPATHOLOGY; HUMAN; HYPERTENSION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; PRIORITY JOURNAL; SIDE EFFECT;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; BRAIN NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; GLIOMA; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; RISK FACTORS;

EID: 33644843627     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6603000     Document Type: Article

References (22)

1. Batty GD, Shipley MJ, Marmot MG, Davey Smith G (2003) Blood pressure and site-specific cancer mortality: evidence from the original Whitehall Study. Br J Cancer 89: 1243-1247
2. Beiderbeck AB, Holly EA, Sturkenboom MC, Coebergh JW, Stricker BH, Leufkens HG (2003) Prescription medications associated with a decreased risk of non-Hodgkin's lymphoma. Am J Epidemiol 157: 510-516
3. Choi MY, Jee SH, Sull JW, Nam CM (2005) The effect of hypertension on the risk for kidney cancer in Korean men. Kidney Int 67: 647-652
4. Fryzek JP, Poulsen AH, Johnsen SP, McLaughlin JK, Sorensen HT, Friis S (2005) A cohort study of antihypertensive treatments and risk of renal cell cancer. Br J Cancer 92: 1302-1306
5. Grossman E, Messerli FH, Goldbourt U (2001) Antihypertensive therapy and the risk of malignancies. Eur Heart J 22: 1343-1352
6. Herings R (1993) Pharmo, A Record Linkage System for Postmarketing Surveillance of Prescription Drugs in The Netherlands (Dissertation). The Netherlands: Utrecht University
7. Houben MPWA, Louwman WJ, Tijssen CC, Teepen JLJM, Van Duijn CM, Coebergh JWW (2004) Hypertension as a risk factor for glioma? Evidence from a population-based study of comorbidity in glioma patients. Ann Oncol 15: 1256-1260
8. Karlsson P, Holmberg E, Lundell M, Mattsson A, Holm LE, Wallgren A (1998) Intracranial tumors after exposure to ionizing radiation during infancy: a pooled analysis of two Swedish cohorts of 28 008 infants with skin hemangioma. Radiat Res 150: 357-364
9. Kleihues P, Cavenee WK (2000) Pathology & Genetics of Tumours of the Central Nervous System. World Health Organization Classification of Tumours. Lyon, France: IARC Press
10. Kuijten RR, Bunin GR, Nass CC, Meadows AT (1990) Gestational and familial risk factors for childhood astrocytoma: results of a case-control study. Cancer Res 50: 2608-2612
11. Lau HS, de Boer A, Beuning KS, Porsius A (1997) Validation of pharmacy records in drug exposure assessment. J Clin Epidemiol 50: 619-625
12. Louis DN, von Deimling A (1995) Hereditary tumor syndromes of the nervous system: overview and rare syndromes. Brain Pathol 5: 145-151
13. McCredie M, Maisonneuve P, Boyle P (1994) Antenatal risk factors for malignant brain tumours in New South Wales children. Int J Cancer 56: 6-10
14. McKean-Cowdin R, Pogoda JM, Lijinsky W, Holly EA, Mueller BA, Preston-Martin S (2003) Maternal prenatal exposure to nitrosatable drugs and childhood brain tumours. Int J Epidemiol 32: 211-217
15. Melean G, Sestini R, Ammannati F, Papi L (2004) Genetic insights into familial tumors of the nervous system. Am J Med Genet C Semin Med Genet 129: 74-84
16. Paganini-Hill A, Ross RK (1982) Reliability of recall of drug usage and other health-related information. Am J Epidemiol 116: 114-122
17. Preston-Martin S, Yu MC, Benton B, Henderson BE (1982) N-Nitroso compounds and childhood brain tumors: a case-control study. Cancer Res 42: 5240-5245
18. Ron E, Modan B, Boice Jr JD, Alfandary E, Stovall M, Chetrit A, Katz L (1988) Tumors of the brain and nervous system after radiotherapy in childhood. N Engl J Med 319: 1033-1039
19. Ryan P, Lee MW, North B, McMichael AJ (1992) Risk factors for tumors of the brain and meninges: results from the Adelaide Adult Brain Tumor Study. Int J Cancer 51: 20-27
20. van der Sanden GA, Schouten LJ, van Dijck JA, van Andel JP, Coebergh J (1998) Incidence of primary central nervous system cancers in South and East Netherlands in 1989-1994. Neuroepidemiology 17: 247-257
21. WHO (1990) Guidelines for ATC Classification. Oslo: WHO Collaborating Centre for Drug Statistics Methodology - Nordic Council on Medicines
22. Wrensch M, Minn Y, Chew T, Bondy M, Berger MS (2002) Epidemiology of primary brain tumors: current concepts and review of the literature. Neuro-oncology 4: 278-299